Evolve Biosystems

OverviewSuggest Edit

Evolve BioSystems is dedicated to developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.
Building on a decade of expertise in the partnership between the infant gut microbiome and human breast milk, Evolve is solving newborn gut dysbiosis, or an imbalance of beneficial bacteria, through microbiome-based interventions in both human and animal health.

HQDavis, US

Recent NewsAll News

Latest Updates

Employees (est.) (May 2020)48(+3%)

Key People/Management at Evolve Biosystems

Timothy B. Brown

Timothy B. Brown

Chief Executive Officer
David Kyle

David Kyle

Chairman of the Board, Chief Scientific Officer
Sandy Argabrite

Sandy Argabrite

Chief Financial Officer
Samara Freeman

Samara Freeman

Director, IP & Regulatory Affairs
Steven Frese

Steven Frese

Director, Microbiology & Bioinformatics
Duane Maye

Duane Maye

Director, Animal Health
Show more

Evolve Biosystems Office Locations

Evolve Biosystems has an office in Davis
Davis, US (HQ)
2121 2nd St b107
Show all (1)

Evolve Biosystems Financials and Metrics

Summary Metrics

Founding Date


Evolve Biosystems total Funding

$69 m

Evolve Biosystems latest funding size

$40 m

Time since last funding

2 years ago

Evolve Biosystems investors

Evolve Biosystems's latest funding round in June 2018 was reported to be $40 m. In total, Evolve Biosystems has raised $69 m
Show all financial metrics

Evolve Biosystems Online and Social Media Presence

Embed Graph

Evolve Biosystems News and Updates

Evolve Biosystems snags $20 mln Series B

Davis, California-based Evolve Biosystems, a microbiome company, has raised $20 million in Series B financing. Spruce Capital Partners/MLS led the round with participation from other investors that include Horizons Ventures, Tate & Lyle Ventures, Bow Capital and Acre Venture Partners.

Evolve Biosystems Blogs

UC Davis Scientific Team Strengthens Case for Bifidobacterium in the Fight Against Antibiotic Resistance

A new study published in mSphere found that children with higher levels of the beneficial bacteria, Bifidobacterium, in their gut microbiome had reduced abundance and lower frequency of antimicrobial resistance (AMR) genes.

First-Ever Rapid Response Test for Levels of Bifidobacterium in Baby’s Gut Microbiome

Evivo® infant stool test prototype is the first ever point-of-care screening test to provide a clear window into infant gut health

New Study Reveals Activated B. Infantis EVC001 Reduces Colonic Mucin Degradation in Babies

The beneficial bacterium found in Evivo® baby probiotic is clinically shown to support a protective intestinal environment in infants.

Significant Reduction in Pathogenic Gut Bacteria Lowers Potential for Infection Risk in Infants Fed B. infantis EVC001

Evolve BioSystems, Inc. (www.evolvebiosystems.com) announced publication of a study showing that two weeks of supplementation with Bifidobacterium longum subsp. infantis EVC001 (B. infantis EVC001, currently available to consumers as Evivo® baby probiotic) in breastfed infants led to an 85 perce…
Show more

Evolve Biosystems Frequently Asked Questions

  • When was Evolve Biosystems founded?

    Evolve Biosystems was founded in 2012.

  • Who are Evolve Biosystems key executives?

    Evolve Biosystems's key executives are Timothy B. Brown, David Kyle and Sandy Argabrite.

  • How many employees does Evolve Biosystems have?

    Evolve Biosystems has 48 employees.

  • Who are Evolve Biosystems competitors?

    Competitors of Evolve Biosystems include Digbi Health, Sun Genomics and Nell Health.

  • Where is Evolve Biosystems headquarters?

    Evolve Biosystems headquarters is located at 2121 2nd St b107, Davis.

  • Where are Evolve Biosystems offices?

    Evolve Biosystems has an office in Davis.

  • How many offices does Evolve Biosystems have?

    Evolve Biosystems has 1 office.